Objectives: In this study we reviewed our practice of lung cancer epidermal growth factor receptor (EGFR) mutational testing in an academic centralized laboratory setting, where direct smears and liquid-based cytology (LBC) slides represent the most frequent cytological specimens received. The aim was to assess the differences, if any, between these sample types in terms of DNA yield, adequacy rates and overall EGFR testing performance. Study Design: A total of 362 cases were retrieved - received from January 2012 to January 2014 for EGFR testing - including 204 LBC specimens and 158 smears. Exon 19 deletions and the L858R point mutation in exon 21, detected by fragment assay and TaqMan assay, respectively, were confirmed by direct sequencing or by high-resolution melting. Results: Although the direct smears showed a higher DNA yield (60.94 vs. 23.07 ng/µl) and were more frequently cell-rich (54%) than the LBC slides (31.4%), the differences in adequacy (direct smears: 97.4%; LBCs: 94.1%) and in mutant rate (direct smears: 10.3%; LBCs: 14.0%) between the two sample types did not reach statistical significance. Conclusions: Not only direct smears but also LBC slides represent an effective preparation and storage medium for cytological material to be used for EGFR molecular testing.

Keywords:
Epidermal growth factor receptor test, Nonsmall-cell lung cancer, Liquid-based cytology
1.
Bellevicine C, Malapelle U, de Luca C, Iaccarino A, Troncone G: EGFR analysis: current evidence and future directions. Diagn Cytopathol 2014;42:984-992.
2.
Collins BT, Chen AC, Wang JF, Bernadt CT, Sanati S: Improved laboratory resource utilization and patient care with the use of rapid on-site evaluation for endobronchial ultrasound fine-needle aspiration biopsy. Cancer Cytopathol 2013;121:544-551.
3.
Bonifazi M, Sediari M, Ferretti M, et al: The role of the pulmonologist in rapid on-site cytologic evaluation of transbronchial needle aspiration: a prospective study. Chest 2014;145:60-65.
4.
Herbert A, Anic V, Cochand-Priollet B, et al: Training and practice of cytotechnologists: a discussion forum focused on Europe. Cytopathology 2014;25:307-315.
5.
Al-Abbadi MA, Bloom LI, Fatheree LA, et al: Adequate reimbursement is crucial to support cost-effective rapid on-site cytopathology evaluations. Cytojournal 2010;7:22.
6.
Celik B, Khoor A, Bulut T, Nassar A: Rapid on-site evaluation has high diagnostic yield differentiating adenocarcinoma vs squamous cell carcinoma of non-small cell lung carcinoma, not otherwise specified subgroup. Pathol Oncol Res 2014, Epub ahead of print.
7.
Fischer AH, Benedict CC, Amrikachi M: Five top stories in cytopathology. Arch Pathol Lab Med 2013;137:894-906.
8.
Lee YS, Jin GY, Han YM, Chung MJ, Park HS: Computed tomography-guided transthoracic needle aspiration biopsy of intrapulmonary lesions: utility of a liquid-based cytopreparatory technique. Acta Cytol 2008;52:665-670.
9.
Konofaos P, Tomos P, Malagari K, et al: The role of ThinPrep cytology in the investigation of lung tumors. Surg Oncol 2006;15:173-178.
10.
Malapelle U, Bellevicine C, De Luca C, et al: EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non-small cell lung carcinoma patients. Cancer Cytopathol 2013;121:552-560.
11.
Aisner DL, Deshpande C, Baloch Z, et al: Evaluation of EGFR mutation status in cytology specimens: an institutional experience. Diagn Cytopathol 2013;41:316-323.
12.
Dejmek A, Zendehrokh N, Tomaszewska M, Edsjö A: Preparation of DNA from cytological material: effects of fixation, staining, and mounting medium on DNA yield and quality. Cancer Cytopathol 2013;121:344-353.
13.
Kawahara A, Taira T, Abe H, et al: Fixation effect of SurePath preservative fluids using epidermal growth factor receptor mutation-specific antibodies for immunocytochemistry. Cancer Cytopathol 2014;122:145-152.
14.
Malapelle U, De Rosa N, Rocco D, et al: EGFR and KRAS mutations detection on lung cancer liquid-based cytology: a pilot study. J Clin Pathol 2012;65:87-91.
15.
Malapelle U, De Rosa N, Bellevicine C, et al: EGFR mutations detection on liquid-based cytology: is microscopy still necessary? J Clin Pathol 2012;65:561-564.
16.
Petriella D, Galetta D, Rubini V, et al: Molecular profiling of ThinPrep FNA samples in assisting clinical management of non-small-cell lung cancer. Mol Biotechnol 2013;54:913-919.
17.
Wu C-Y, Hou L-K, Ren S-X, Su B, Chen G: High feasibility of liquid-based cytological samples for detection of EGFR mutations in Chinese patients with NSCLC. Asian Pac J Cancer Prev 2014;15:7885-7889.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.